BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 170516)

  • 1. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
    N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pseudohypoparathyroidism with 1 alpha-hydroxyvitamin D3.
    Furukawa Y; Sohn H; Unakami H; Yumita S
    Contrib Nephrol; 1980; 22():68-73. PubMed ID: 7398339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism.
    Okano K; Furukawa Y; Morii H; Fujita T
    J Clin Endocrinol Metab; 1982 Aug; 55(2):238-43. PubMed ID: 6979550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age on the conversion of 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 by kidney of rat.
    Armbrecht HJ; Zenser TV; Davis BB
    J Clin Invest; 1980 Nov; 66(5):1118-23. PubMed ID: 6893596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: The pieces of a vitamin D puzzle fall into place--almost!
    Wright DR
    N Engl J Med; 1975 Oct; 293(17):872-3. PubMed ID: 170517
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pseudohypoparathyroidism type I and vitamin D therapy].
    Kovarik J; Weissel M; Neuwirth G; Krepler P; Willvonseder R
    Acta Med Austriaca; 1978; 5(3):106-9. PubMed ID: 222102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: 1,25-Dihydroxyvitamin D3 and pseudohypoparathyroidism.
    Sinha TK; Bell NH
    N Engl J Med; 1976 Mar; 294(11):612. PubMed ID: 1246249
    [No Abstract]   [Full Text] [Related]  

  • 8. Calcium and phosphate metabolism in children with idiopathic hypoparathyroidism or pseudohypoparathyroidism: effects of 1,25-dihydroxyvitamin D3.
    Chan JC; Young RB; Hartenberg MA; Chinchilli VM
    J Pediatr; 1985 Mar; 106(3):421-6. PubMed ID: 3838346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Fraser D; Kooh SW; Kind HP; Holick MF; Tanaka Y; DeLuca HF
    N Engl J Med; 1973 Oct; 289(16):817-22. PubMed ID: 4357855
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.
    Collins MT; Lindsay JR; Jain A; Kelly MH; Cutler CM; Weinstein LS; Liu J; Fedarko NS; Winer KK
    J Bone Miner Res; 2005 Nov; 20(11):1944-50. PubMed ID: 16234967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
    Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
    Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
    Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
    Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D metabolism.
    Holick MF; DeLuca HF
    Annu Rev Med; 1974; 25():349-67. PubMed ID: 4363209
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
    Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
    N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D-deficiency in the elderly: treatment with ergocalciferol and hydroxylated analogues of vitamin D3.
    Shany S; Chaimovitz C; Yagev R; Bercovich M; Lowenthal MN
    Isr J Med Sci; 1988 Mar; 24(3):160-3. PubMed ID: 3259568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoparathyroidism during pregnancy: treatment with calcitriol.
    Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism.
    Kind HP; Prader A; DeLuca HF; Gugler E
    Lancet; 1975 May; 1(7916):1145-6. PubMed ID: 49505
    [No Abstract]   [Full Text] [Related]  

  • 20. Current therapy of hypoparathyroidism--a survey of German endocrinology centers.
    Schilling T; Ziegler R
    Exp Clin Endocrinol Diabetes; 1997; 105(4):237-41. PubMed ID: 9285213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.